Sun Pharma announces agreement to acquire 60% of Vivaldis Health And Foods

Recently, Sun Pharma has also acquired Concert, a US-based pharmaceuticals firm, in January. The Mumbai-based company inked a pact to acquire Concert in a USD 576 million deal. 

Sun Pharma announces agreement to acquire 60% of
On Friday, the company's share price ended 0.46 per cent down at Rs. 972.80 on BSE.

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x